LOS ANGELES, CA / ACCESS Newswire / January 16, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

Enfusion, Inc. (NYSE: ENFN)'s sale to Clearwater Analytics for $5.85 per share in cash and $5.40 per share in Clearwater Class A Common Stock. If you are an Enfusion shareholder, click here to learn ...

Arma Reforgerwill be holding a new modding competition, as players will compete for cash and prizes for the best job done ...

Arma Reforger has started gaining popularity in the FPS community after the recent release of its PlayStation version and ...

Enfusion (NYSE:ENFN – Get Free Report)‘s stock had its “market perform” rating reaffirmed by equities research analysts at ...

Clearwater Analytics (NYSE: CWAN) and Enfusion, Inc. (NYSE: ENFN) announced their entry into a definitive merger agreement.

Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share.With the bid ...

NEW YORK CITY, NY / ACCESSWIRE / January 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between ...

Stifel analyst J. Parker Lane downgraded Enfusion (ENFN) to Hold from Buy with a price target of $11.25, down from $13, after the company announced an agreement to be acquired by Clearwater Analytics ...

Morgan Stanley has recently resumed Enfusion Inc (ENFN) stock to Overweight rating, as announced on May 10, 2024, according to Finviz. Earlier, on February 28, 2024, Goldman had reduced the stock from ...

Enfusion management expects preliminary full year 2024 revenue of approximately $201-202 million, representing 15-16% year on ...